121 related articles for article (PubMed ID: 1942334)
1. Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1991 Dec; 146(6):1530-4. PubMed ID: 1942334
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study.
Tachibana M; Miyakawa A; Miyakawa M; Saito S; Nakamura K; Baba S; Murai M
Cancer Detect Prev; 1999; 23(2):155-62. PubMed ID: 10101597
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
Vindeløv LL; Christensen IJ; Engelholm SA; Guldhammer BH; Højgaard K; Sørensen BL; Wolf H
Cytometry; 1995 Jun; 22(2):93-102. PubMed ID: 7587754
[TBL] [Abstract][Full Text] [Related]
6. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas.
Murphy WM; Chandler RW; Trafford RM
J Urol; 1986 Apr; 135(4):694-7. PubMed ID: 3959188
[TBL] [Abstract][Full Text] [Related]
8. A new scoring system based on the histological behavior and proliferative activity of tumor cells for grading the malignant potential of bladder cancers.
Tachibana M; Miyakawa A; Deguchi N; Baba S; Murai M; Tazaki H
Int J Urol; 1994 Mar; 1(1):37-42. PubMed ID: 7627836
[TBL] [Abstract][Full Text] [Related]
9. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
[TBL] [Abstract][Full Text] [Related]
10. Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma.
Hofstaedter F; Jakse G; Lederer B; Mikuz G; Delgado R
Br J Urol; 1984 Jun; 56(3):289-95. PubMed ID: 6544613
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
12. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumor invasiveness of upper tract urothelial cancer.
Miyakawa A; Tachibana M; Nakashima J; Deguchi N; Baba S; Tazaki H
J Urol; 1994 Jul; 152(1):76-80. PubMed ID: 8201694
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
16. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
17. Image cytometric DNA analysis in transitional cell carcinoma of the bladder.
Schapers RF; Ploem-Zaaijer JJ; Pauwels RP; Smeets AW; van den Brandt PA; Tanke HJ; Bosman FT
Cancer; 1993 Jul; 72(1):182-9. PubMed ID: 8508404
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
[TBL] [Abstract][Full Text] [Related]
19. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
Lipponen PK; Eskelinen MJ; Nordling S
Eur J Cancer; 1991; 27(7):877-81. PubMed ID: 1834120
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
